MarketsandMarkets: Global DNA and Gene Chip (Microarrays) Market to Reach $1,425.2 Million by 2015

DALLAS, May 17, 2011 - The "Global DNA and Gene Chip (Microarrays) Market (2008 - 2015)"
analyzes the DNA microarray market by types and applications and studies the
major market drivers, restraints, opportunities, and market trends for the
DNA microarray market in North America, Europe, Asia, and Rest of the World.

Browse market data tables and in-depth TOC on Global DNA and Gene Chip
(Microarrays) Market (2008 - 2015).
www.marketsandmarkets.com/Market-Reports/genechips-367.html Early
buyers will receive 10% customization of reports.

Microarrays were developed and commercialized in the eighties. Since
then, market has offered tremendous growth and hence has seen an influx of
players vying fiercely for a share or this market. The Global DNA & Gene Chip
(microarray) market was valued at $760 million in 2010 and is expected to
reach $1,425.2 million by 2015 growing at a CAGR of 13.4%. Major players in
this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent
Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), Sequenom Inc, (U.S.), and
others.

New product launches and agreements and collaborations are the two main
strategies adopted by the players to stay competitive in this market.
Although gene expression has been the dominant application of these chips,
cancer diagnostics and treatment will lead the market in 2015 with a share of
24.2% as more and more companies invest in diagnostic chips since early
detection of the disease and targeted treatment options are still the unmet
need of this market. There were 12.3 million new cases of cancer worldwide in
2007 and about 7.6 million deaths. These figures are estimated to rise up to
16 million new cancer diagnoses cases and about 10 million deaths by 2020
according to WHO & American Cancer Society.

Scope of the report

This research report categorizes the Global DNA & Gene Chip (microarray)
market on the basis of applications, types, and geography; forecasting
revenues and analyzing trends in each of the following submarkets:

On the basis of applications

Gene Expression, cancer diagnostics & treatments, drug discovery,
genetics (DNA sequencing by hybridization, reverse genetics, functional
genomics and genomic mismatch scanning, gene mapping, diagnosis), SNP
analysis, screening & monitoring of patient data during clinical trials,
proteomics, toxicogenomics, microbial genotyping, agricultural biology, and
environmental control.

On the basis of types

Oligonucleotide DNA Microarrays (oDNA) and Complementary DNA Microarrays
(cDNA)

On the basis of geography

North America, Europe, Asia, and Rest of the World

About Us

MarketsandMarkets (M&M) is a global market research and consulting
company based in the U.S. We publish strategically analyzed market research
reports and serve as a business intelligence partner to Fortune 500 companies
across the world. MarketsandMarkets also provides multi-client reports,
company profiles, databases, and custom research services.

M&M covers thirteen industry verticals; including advanced materials,
automotives and transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy and power, food and
beverages, industrial automation, medical devices, pharmaceuticals,
semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website
www.marketsandmarkets.com

    Contact:
    Mr. Rohan
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-6006-441
    Email: sales@marketsandmarkets.com

    www.marketsandmarkets.com
    marketsandmarkets.blogspot.com
    twitter.com/marketsmarkets

.